![malignancies](https://www.adcreviews.com/wp-content/uploads/2022/07/malignancies-300x150.jpeg)
Brooklyn: Phase II Results of IRX-2
On July 26, Brooklyn announced results from the Phase II INSPIRE trial of IRX-2, a multi-cytokine biological immunotherapy. The trial was designed to evaluate the
On July 26, Brooklyn announced results from the Phase II INSPIRE trial of IRX-2, a multi-cytokine biological immunotherapy. The trial was designed to evaluate the